Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis

Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis

ObjectiveTo compare the cumulative live birth rate (CLBR) of the progestin-primed ovarian stimulation (PPOS) protocol with that of the flexible GnRH antagonist protocol in patients with poor prognosis diagnosed per the POSEIDON criteria.MethodsThis was a retrospective cohort study. Low-prognosis wom...

Full description

Bibliographic Details
Main Authors:	Mingze Du, Junwei Zhang, Zhen Li, Xinmi Liu, Jing Li, Wenxia Liu, Yichun Guan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Endocrinology
Subjects:	progestin-primed ovarian stimulation GnRH antagonist low prognosis cumulative live birth rate controlled ovarian hyperstimulation
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2021.705264/full

Similar Items

Progestin-Primed Ovarian Stimulation versus GnRH Antagonist Protocol for Ovarian Stimulation in IVF: A Prospective Pilot Study
by: Tien K. Le, et al.
Published: (2024-03-01)

Non-inferiority of progestin-primed ovarian stimulation versus GnRH antagonist protocol: A propensity score-weighted analysis
by: Le Duc Thang, et al.
Published: (2024-04-01)

GnRH Antagonist/Letrozole Versus Microdose GnRH Agonist Flare Protocol in Poor Responders Undergoing In Vitro Fertilization
by: Robab Davar, et al.
Published: (2010-09-01)

Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle
by: Erkan Kalafat, et al.
Published: (2022-05-01)

Comparison of the neonatal outcomes of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols: a propensity score–matched cohort study
by: Mingze Du, et al.
Published: (2023-06-01)

A novel GnRH-antagonist protocol by switching to medroxyprogesterone when patients being at risk of ovarian hyperstimulation syndrome during ovarian stimulation
by: Ting-Chi Huang, et al.
Published: (2020-11-01)

Cumulative Live Birth Rates After the First ART Cycle Using Flexible GnRH Antagonist Protocol vs. Standard Long GnRH Agonist Protocol: A Retrospective Cohort Study in Women of Different Ages and Various Ovarian Reserve
by: Wanlin Zhang, et al.
Published: (2020-05-01)

Comparison of pregnancy outcome after fresh embryo transfer between GnRH antagonist and GnRH agonist regimens in patients with thin endometrium
by: Depeng Zhao, et al.
Published: (2023-01-01)

GnRH agonist versus GnRH antagonist in <it>in vitro</it> fertilization and embryo transfer (IVF/ET)
by: Depalo Raffaella, et al.
Published: (2012-04-01)

Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study
by: Shan Liu, et al.
Published: (2021-07-01)

Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations
by: Ruiqiong Zhou, et al.
Published: (2023-04-01)

Meta-analysis of trigger timing in normal responders undergoing GnRH antagonist ovarian hyperstimulation protocol
by: Qijun Xie, et al.
Published: (2024-03-01)

Recent Development of Non-Peptide GnRH Antagonists
by: Feng-Ling Tukun, et al.
Published: (2017-12-01)

Micronized natural progesterone (Seidigestan®) vs GnRH antagonists for preventing the LH surge during controlled ovarian stimulation (PRO_NAT study): study protocol of a randomized clinical trial
by: M. Martínez-Moya, et al.
Published: (2024-03-01)

Editorial: GnRH agonist triggering of final oocyte maturation: Improving safety without compromising success
by: Johnny Awwad, et al.
Published: (2023-03-01)

GnRH Agonist Triggering of Ovulation Replacing hCG: A 30-Year-Old Revolution in IVF Practice Led by Rambam Health Care Campus
by: Shahar Kol, et al.
Published: (2017-04-01)

GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis
by: M.A.F. Youssef, et al.
Published: (2015-05-01)

Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist
by: Mu Lv, et al.
Published: (2022-10-01)

Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response
by: Junwei Zhang, et al.
Published: (2021-09-01)

Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval
by: Tzu-Ching Kao, et al.
Published: (2023-01-01)

Co-administration of GnRH-agonist and hCG (double trigger) for final oocyte maturation increases the number of top-quality embryos in patients undergoing IVF/ICSI cycles
by: Binbin Tu, et al.
Published: (2024-07-01)

Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer
by: Carsten Gründker, et al.
Published: (2021-02-01)

Micro-dose flare-up gonadotrophin-releasing hormone (GnRH) agonist vs. flexible gonadotrophin-releasing hormone (GnRH) antagonist protocol in patient with poor ovarian reserve
by: Zakia Mahdy Ibrahim, et al.
Published: (2011-12-01)

GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran
by: Ensieh Tehraninejad, et al.
Published: (2011-01-01)

Comparison the effects of progestin-primed ovarian stimulation (PPOS) protocol and GnRH-a long protocol in patients with normal ovarian reserve function
by: Shaoyuan Xu, et al.
Published: (2023-12-01)

Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial
by: Qiuju Chen, et al.
Published: (2019-11-01)

A prediction model for high ovarian response in the GnRH antagonist protocol
by: Yilin Jiang, et al.
Published: (2023-11-01)

Editorial: Recent advances in progestin-primed ovarian stimulation
by: Qiuju Chen
Published: (2022-11-01)

An Individualized Recommendation for Controlled Ovary Stimulation Protocol in Women Who Received the GnRH Agonist Long-Acting Protocol or the GnRH Antagonist Protocol: A Retrospective Cohort Study
by: Ming-Xing Chen, et al.
Published: (2022-07-01)

Predictive factors of ovarian response to GnRH antagonist stimulation protocol: AMH and age are potential candidates
by: Mohammed M. Laqqan, et al.
Published: (2021-05-01)

Long GnRH Agonist versus GnRH Antagonist Protocols in Women with Endometrioma and Good Ovarian Reserve Undergoing IVF/ICSI Cycles
by: Maryam Eftekhar, et al.
Published: (2023-01-01)

The role of GnRH metabolite, GnRH-(1-5), in endometrial cancer
by: Madelaine J. Cho-Clark, et al.
Published: (2023-04-01)

Comparison of clinical effects between early follicular prolonged GnRH agonist protocol and GnRH antagonist protocol in 3310 cycles: a retrospective study
by: Juan Gui, et al.
Published: (2022-12-01)

GnRH Induces ERK-Dependent Bleb Formation in Gonadotrope Cells, Involving Recruitment of Members of a GnRH Receptor-Associated Signalosome to the Blebs
by: Liat Rahamim-Ben Navi, et al.
Published: (2017-06-01)

Ovarian Dynamic in Ongole Grade Cattle after GnRH Injection in Ovsynch Protocol Based on Progesterone Device
by: M. Imron, et al.
Published: (2015-08-01)

Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study
by: Shaodi Zhang, et al.
Published: (2021-06-01)

GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial
by: Francesco M. Fusi, et al.
Published: (2019-11-01)

Serum Oestradiol Pattern during Coasting is Different in Antagonist Cycles Compared with Long Agonist Cycles in In Vitro Fertilisation
by: Koray Elter, et al.
Published: (2013-12-01)

GnRH Antagonist Protocol Versus GnRH Agonist Long Protocol: A Retrospective Cohort Study on Clinical Outcomes and Maternal-Neonatal Safety
by: Jieru Zhu, et al.
Published: (2022-06-01)

Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis
by: Liting Zhang, et al.
Published: (2022-12-01)